15 Mar 2017 GSK announces US regulatory submission seeking expanded indication for Fluarix® Quadrivalent (Influenza Vaccine) for infants 6 months and older
15 Mar 2017 BriaCell Receives FDA Clearance to Initiate Phase I/IIa Clinical Trial of BriaVax(TM) in Patients with Advanced Breast Cancer
14 Mar 2017 First Patient Dosed in Phase 2 Trial Evaluating Transgene’s TG4010 in Combination With Opdivo® (Nivolumab) for 2nd Line Treatment of Metastatic Non-Small Cell Lung Cancer (NSCLC)
13 Mar 2017 Bavarian Nordic Announces Collaboration to Evaluate CV301 and Tecentriq in Bladder Cancer
09 Mar 2017 CyTuVax starts its Phase 2 BE RESPONDER! study
07 Mar 2017 Aimmune Therapeutics Presents Clinical Data on Phase 3 Screening and Phase 2 Adherence for AR101 for Peanut Allergy at the 2017 American Academy of Allergy, Asthma & Immunology (AAAAI) Annual Meeting
02 Mar 2017 FDA approves Odactra for house dust mite allergies
28 Feb 2017 Astellas and Affinivax Announce Worldwide Partnership for MAPS Vaccine targeting Pneumococcal Disease
28 Feb 2017 Inovio’s SynCon® WT1 Cancer Antigen Breaks Tolerance, Highlights Potential for Universal Cancer Immunotherapy
27 Feb 2017 In First Phase 3 Trial, Merck’s Investigational Inactivated Varicella Zoster Virus Vaccine (V212) Reduced the Incidence of Confirmed Herpes Zoster Cases by an Estimated 64 Percent in Immunocompromised Subjects
24 Feb 2017 Oxford BioMedica Notes Encouraging Results of the Investigator Led Phase I/II clinical trial of MVA-5T4 Immunotherapy (TroVax®) and Low Dose Cyclophosphamide in Patients with Advanced Colorectal Cancer
23 Feb 2017 Inovio Reports New Positive Clinical Data on Vaccine Advances in the Fight Against Emerging Infectious Diseases
22 Feb 2017 Independent Data Monitoring Committee Recommends Discontinuation of the ADAPT Phase 3 Clinical Trial of Rocapuldencel-T in Metastatic Renal Cell Carcinoma for Futility Following Its Planned Interim Data Review
22 Feb 2017 ImmusanT Announces Completion of Phase 1b Clinical Trial of Nexvax2® for the Treatment of Celiac Disease
22 Feb 2017 hVIVO notes the initiation of a Phase I clinical trial with AGS-v, a mosquito-borne disease vaccine candidate
21 Feb 2017 Apitope Announces Positive ATX-MS-1467 Phase IIa Data in Relapsing Multiple Sclerosis
16 Feb 2017 ALK submits registration application for ragweed SLIT-tablet in Europe
15 Feb 2017 TapImmune Advances TPIV 200 Phase 2 Triple-Negative Breast Cancer Trial After Favorable DSMB Review
14 Feb 2017 Vaxart Announces Positive Phase 1 Study of Oral Norovirus Vaccine
14 Feb 2017 Allergy Therapeutics PLC Announces Novel House Dust Mite Allergy Vaccine Gains Clinical Trial Application Approval
06 Feb 2017 NW Bio Announces Lifting of Clinical Hold on DCVax®-L Phase III Trial By FDA; Progression-Free Survival Events Reached; Overall Survival Events Not Yet Reached
06 Feb 2017 Advaxis Announces First Patient Dosed in Global Phase 3 AIM2CERV Trial for High-risk, Locally Advanced Cervical Cancer
02 Feb 2017 Targovax announces encouraging top line two-year survival data from TG01 clinical trial in resected pancreatic cancer patients
27 Jan 2017 Latest Clinical Data from OncBioMune Supports Safety and Therapeutic Profile of ProscaVax for Prostate Cancer for Upcoming Phase 2 Clinical Trials
26 Jan 2017 Pfizer Announces Positive Top-Line Results from Phase 2 Study of Investigational Clostridium difficile Vaccine for the Prevention of C. difficile Infection

La Merie Biologics

FREE Weekly News Bulletin

2016 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing